Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
18.12.2020
Sernova to Present at H.C. Wainwright BioConnect 2021 Conference
30.11.2020
Sernova Announces Clinical Trial Investigator Presentation at the ASTS 21st Winter Symposium
18.11.2020
Sernova Provides Clinical Update on U.S. Phase I/II Cell Pouch™ Trial for Type 1 Diabetes
04.08.2020
Sernova Enters into Exclusive Worldwide License Agreement with University of Miami for Therapeutic Cell Immune Protection Technologies
16.07.2020
Dr. Anke M. Schulte Joins Sernova Global Advisory Board
18.06.2020
Sernova Highlights Positive Results Presented at the American Diabetes Association’s Virtual 80th Scientific Sessions
15.06.2020
Sernova Completes Acquisition of Cellular Local Immune Protection Technology
08.06.2020
Sernova to Acquire Cellular Local Immune Protection Technology Accelerating Expansion of its Regenerative Medicine Therapeutics Platform
01.06.2020
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A
13.02.2020
Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes
First
Previous
4
5
6
7
8
9
10
Next
Last